Clinical Trials Update: June 10, 2005
Dyslipidemia Epilepsy Multiple Sclerosis
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Have you been told that your lipids (triglycerides, HDL, LDL) are abnormal? If so, you may be interested in a 13-month research study being conducted at Clinical Research Associates in Tennessee. To participate, you should be 18 or older, male with a waist size of greater than 40 inches, or female with waist size of greater than 35 inches, and willing to make lifestyle/dietary changes. Study participants will receive investigational medication, study related dietary counseling, physical examination and laboratory tests at no cost. Research site located in Nashville, Tenn.
The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with partial or PGTC Seizures. Patients must be 13 years and older with a diagnosis of epilepsy with partial (simple or complex) or PGTC seizures for more than six months. Qualified participants must be currently treated with a stable regimen of 1-2 anti-epileptic drugs for at least four weeks prior to entering the study. Research sites located throughout the United States.
This trial is meant for patients who have just begun taking Copaxone for 3 months or less. Eligible participants must be 18 or older with a diagnosis of RRMS. Compensation may be provided if you qualify. Research site located in Columbus, Ohio.
Copyright 2005 CenterWatch. All rights reserved.